Haemato-Oncology Network Site Specific Group Minutes Thursday 15th October 2015 Arundel Arms Hotel, Lifton PL16 0DE This meeting was sponsored by Alexion, Amgen, Gilead, Pfizer, Janssen and Roche. Roche Products Limited has had no control over the educational content. Attendees: Patrick Medd, PHT (Chair) Suzanne Greep, PHT Kerry McKay, PHT Rebecca Hick, PHT Susan Gilbert, PHT Sophie Kendall, PHT Adam Forbes, RCHT Linzi Retallick-Schmid, RCHT Deborah Turner, SDHT Libby Hardy, SWSCN Clare Fox, RDE Wendy Cook, PCRN Liz Boylan, PCN Mel Chandler, PCN ACTION 1. Welcome and Apologies Patrick Medd chaired the meeting, he welcomed the group and apologies were accepted. 2. Minutes/Actions of Meeting held 14TH May 2015 2.1 The minutes of the last meeting were reviewed and accepted by the meeting. Action from last meeting: 2.2 Catchment Population - the RDE and ND meeting the 500,000 requirement. The number shown for RCHT is 534,000 for the whole of Cornwall which is slightly high. Need to ascertain the official number for RCHT. Action: AF to clarify the number on the table. AF 2.3 User Representation - complete as it was agreed we only need one i.e. we do not require one from each MDT. 2.4 Pathology Leads have been confirmed as:- Oncology – Chris Hamilton, RDE Radiology – Richard Riordan, PHT Pathology – Mark Smith,PHT 2.5 Videoconferencing - on hold. Remove item. 2.6 ARIA Pro-Forma - is completed at MDT. Remove item. 2.7 Innovation Funding – Dr Turner said Celgene not interested. Remove item. 3. Terms of Reference 3.1 Approved by members present. 4. Constitution 4.1 Approved by members present. 4.2 It was noted that Loretta Ngu and Clare Fox were the new Joint MDT leads for RDE & ND. Action: LB to update Constitution LB 5. Clinical Guidelines 5.1 The group agreed to sign off the Clinical Haematological Malignancy
Haemato-Oncology Network Site Specific Group Minutes Thursday 15th October 2015 Arundel Arms Hotel, Lifton PL16 0DE This meeting was sponsored by Alexion, Amgen, Gilead, Pfizer, Janssen and Roche. Roche Products Limited has had no control over the educational content. Attendees: Patrick Medd, PHT (Chair) Suzanne Greep, PHT Kerry McKay, PHT Rebecca Hick, PHT Susan Gilbert, PHT Sophie Kendall, PHT Adam Forbes, RCHT Linzi Retallick-Schmid, RCHT Deborah Turner, SDHT Libby Hardy, SWSCN Clare Fox, RDE Wendy Cook, PCRN Liz Boylan, PCN Mel Chandler, PCN ACTION 1. Welcome and Apologies Patrick Medd chaired the meeting, he welcomed the group and apologies were accepted. 2. 2.1 2.2 2.3 2.4 2.5 2.6 2.7 Minutes/Actions of Meeting held 14TH May 2015 The minutes of the last meeting were reviewed and accepted by the meeting. Action from last meeting: Catchment Population - the RDE and ND meeting the 500,000 requirement. The number shown for RCHT is 534,000 for the whole of Cornwall which is slightly high. Need to ascertain the official number for RCHT. Action: AF to clarify the number on the table. User Representation - complete as it was agreed we only need one i.e. we do not require one from each MDT. Pathology Leads have been confirmed as:- Oncology – Chris Hamilton, RDE Radiology – Richard Riordan, PHT Pathology – Mark Smith,PHT Videoconferencing - on hold. Remove item. ARIA Pro-Forma - is completed at MDT. Remove item. Innovation Funding – Dr Turner said Celgene not interested. Remove item. AF 3. 3.1 Terms of Reference Approved by members present. 4. 4.1 4.2 Constitution Approved by members present. It was noted that Loretta Ngu and Clare Fox were the new Joint MDT leads for RDE & ND. Action: LB to update Constitution LB 5. 5.1 Clinical Guidelines The group agreed to sign off the Clinical Haematological Malignancy
Haemato-Oncology-NSSG-Final-Minutes-15.10.15-approved-by-PM1.docx